Post-Operative Atrial Arrhythmias after Lung Transplantation: A Single Center Analysis of Risk Factors, Management, and Outcomes
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Following lung transplant, many patients develop post-operative atrial fibrillation (AF) or atrial flutter (AFL)–collectively defined as post-operative atrial arrhythmia (POAA). While early (in-hospital) POAA is linked to increased mortality, late (post-discharge) POAA is poorly understood. Risk factors and real-world management strategies for POAA are not well characterized. We aim to evaluate POAA incidence and timing, identify risk and protective factors, and assess associations with mortality and long-term outcomes.
Methods
This retrospective cohort study included 233 adult lung transplant recipients at Northwestern Memorial Hospital (2014–2024), excluding those with pre-existing AF or AFL. POAA was confirmed by ECG or Holter. Adjusted logistic and Cox regressions identified predictors of POAA and mortality.
Results
Of 233 recipients (age 58.6±12.8y, 45.1% female), POAA occurred in 29.6% (53.6% AF, 24.6% AFL, 21.7% both). Both overall (HR4.06, 95%CI[2.21–7.46]) and late (HR3.01, 95%CI[1.39–6.53]) POAA were significantly associated with mortality. 14.5% of patients with POAA required hospital-based arrhythmia management and 66.6% underwent additional rhythm control (2.9%% DCCV, 46.4% AAD initiation, 17.4% both). Preoperative pulmonary arterial hypertension (PAH) was associated with less POAA (OR0.31, 95%CI[0.14–0.62]). Postoperative beta-blocker use was associated with 73% reduced POAA (HR0.27, 95%CI[0.09–0.80]).
Conclusions
This study is among the first to associate late POAA with mortality and define arrhythmia-related hospitalization rates after POAA. Postoperative beta-blockers were associated with significantly less POAA, a novel finding in lung transplant recipients. Finally, preoperative PAH’s association with less POAA might reflect reduced cardiac strain post-transplant.
